Last reviewed · How we verify
weekly cabazitaxel
At a glance
| Generic name | weekly cabazitaxel |
|---|---|
| Sponsor | Jeffrey Yachnin M.D., PhD. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Bristol Bladder Trial (PHASE2)
- A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse (PHASE3)
- Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer (PHASE1)
- Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy (PHASE2)
- A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer (PHASE2)
- Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a Docetaxel (PHASE3)
- Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer (PHASE2)
- Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |